Latest filing published 12 Feb 2026 for HCA Healthcare, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jon M. Foster (chief executive) discloses dealings in HCA Healthcare, Inc. to SEC (Form 4). Over a trading history stretching from 12 May 2021 to 10 February 2026, the count stands at 12 filings.
Sales make up the whole of the open-market record (1 sale, €5.2M). The rest of the record consists of 5 share grants and 3 option exercises.
The newest entry dates from 12 February 2026: a share grant, in HCA Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations